dacarbazine and Gliosarcoma

dacarbazine has been researched along with Gliosarcoma in 25 studies

Research

Studies (25)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	7 (28.00)	29.6817
2010's	16 (64.00)	24.3611
2020's	2 (8.00)	2.80

Authors

Authors	Studies
Iorgulescu, JB; Kavouridis, VK; Ligon, KL; Wen, PY	1
Li, D; Ma, JP; Wang, L; Weng, JC; Wu, Z; Zhang, JT; Zhang, Y	1
Bow, H; Brem, H; Hwang, LS; Murray, L; Salditch, Q; Schildhaus, N; Tyler, B; Weingart, J; Xing, J; Ye, X; Zhang, Y	1
Brown, PD; McAleer, MF	1
Gandhi, AK; Gupta, S; Haresh, KP; Julka, PK; Mallick, S; Rath, GK; Sharma, DN	1
Adeberg, S; Bernhardt, D; Debus, J; Diehl, C; Harrabi, SB; Koelsche, C; Rieken, S; Unterberg, A; von Deimling, A	1
Antoni, D; Berger, A; Biau, J; Castelli, J; Crehange, G; de Crevoisier, R; Feuvret, L; Gutierrez, FL; Haoming, QC; Jouglar, E; Le Reste, PJ; Loussouarn, D; Morandi, X; Noel, G; Nouhaud, E; Thillays, F; Truc, G; Vauleon, E	1
Bräuer-Krisch, E; Bravin, A; Keyriläinen, J; Le Duc, G; Régnard, P; Troprès, I	1
Kikuchi, T; Kumabe, T; Sonoda, Y; Sugiyama, S; Tominaga, T; Yamashita, Y	1
Ehrenreich, H; Giese, A; Hasselblatt, M; Hassouna, I; Jelkmann, W; Kim, E; Rave-Fränk, M; Schulz-Schaeffer, W; Sperling, S	1
Ayers-Ringler, J; Berger, MS; Butowski, N; Carliner, H; Chang, SM; DeBoer, R; Fedoroff, A; Haas-Kogan, DA; James, CD; Kabuubi, P; Lamborn, KR; McDermott, MW; Page, M; Parsa, AT; Parvataneni, R; Prados, MD; Rabbitt, J; Sneed, PK; Stokoe, D; Vandenberg, S	1
Fukushima, T; Inoue, T; Komatsu, F; Ohmura, T; Ohta, M; Oshiro, S; Sakamoto, S; Tsugu, H	1
Ahn, BJ; Berger, MS; Chang, SM; Han, SJ; McDermott, MW; Otero, JJ; Parsa, AT; Tihan, T; Yang, I	1
Ahn, BJ; Berger, MS; Han, SJ; McDermott, MW; Otero, JJ; Parsa, AT; Prados, MD; Tihan, T; Yang, I	1
Bekele, BN; Bobustuc, GC; Colman, H; Conrad, CA; Gilbert, MR; Groves, MD; Hsu, SH; Levin, VA; Puduvalli, VK; Qiao, W; Walbert, T; Yung, WK	1
Basaldella, L; Brem, H; Cima, MJ; Grossman, R; Langer, RS; Masi, BC; Patta, YR; Scott, AW; Tyler, BM; Upadhyay, UM	1
Brat, DJ; Burger, PC; Buxton, A; Cohen, KJ; Hamilton, RL; Heideman, RL; Holmes, EJ; Lavey, RS; Pollack, IF; Rosenblum, MK; Zhou, T	1
Biswas, A; Gupta, K; Kumar, N; Kumar, P; Mathuriya, SN; Patel, F; Sharma, SC; Vasishta, RK	1
Butowski, N; Chang, SM; Clarke, J; Costa, BM; Costello, JF; Hristova-Kazmierski, M; Hsieh, E; Lamborn, KR; Nicol, SJ; Nicole, A; Parvataneni, R; Pieper, R; Polley, MY; Prados, MD; Reis, RM; Sneed, PK; Thornton, DE; Vandenberg, S	1
Brem, H; Grossman, R; Hwang, L; Javaherian, K; Lal, B; Tyler, B; Zadnik, P	1
Bow, H; Brem, H; Cima, MJ; Langer, R; Masi, BC; Tyler, BM; Wicks, RT; Xue, Y	1
Hewer, E; Kappeler, A; Reinert, MM; Vajtai, I; Vassella, E	1
Brown, PD; Gilbert, MR; McAleer, MF; Prabhu, SS; Walker, GV	1
Franz, M; Grosu, AL; Gumprecht, H; Molls, M; Nieder, C; Piert, M; Schwaiger, M; Stärk, S; Thamm, R; Weber, WA	1
Albright, RE; Brada, M; Bruner, J; Fink, K; Fredericks, R; Friedman, H; Glantz, M; Greenberg, H; Hohl, RJ; Levin, VA; Olson, J; Osoba, D; Phillips, P; Prados, MD; Rampling, R; Selker, RG; Shapiro, W; Spence, A; Vick, NA; Yue, N; Yung, WK; Zaknoen, S	1

Reviews

1 review(s) available for dacarbazine and Gliosarcoma

Article	Year
Therapeutic management of gliosarcoma in the temozolomide era. CNS oncology, 2015, Volume: 4, Issue:3 Topics: Antineoplastic Agents, Alkylating; Brain Neoplasms; Dacarbazine; Disease Management; Gliosarcoma; Humans; Temozolomide	2015

Trials

4 trial(s) available for dacarbazine and Gliosarcoma

Article	Year
Phase II study of erlotinib plus temozolomide during and after radiation therapy in patients with newly diagnosed glioblastoma multiforme or gliosarcoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2009, Feb-01, Volume: 27, Issue:4 Topics: Adult; Aged; Antineoplastic Agents, Alkylating; Brain Neoplasms; Combined Modality Therapy; Dacarbazine; Erlotinib Hydrochloride; Glioblastoma; Gliosarcoma; Humans; Middle Aged; Protein Kinase Inhibitors; Quinazolines; Temozolomide	2009
Temozolomide in the treatment of high-grade gliomas in children: a report from the Children's Oncology Group. Neuro-oncology, 2011, Volume: 13, Issue:3 Topics: Adolescent; Adult; Antineoplastic Agents, Alkylating; Brain Neoplasms; Chemotherapy, Adjuvant; Child; Child, Preschool; Combined Modality Therapy; Dacarbazine; Female; Follow-Up Studies; Glioblastoma; Gliosarcoma; Humans; Immunoenzyme Techniques; Male; O(6)-Methylguanine-DNA Methyltransferase; Radiotherapy Dosage; Survival Rate; Temozolomide; Treatment Outcome; Young Adult	2011
Phase II and pharmacogenomics study of enzastaurin plus temozolomide during and following radiation therapy in patients with newly diagnosed glioblastoma multiforme and gliosarcoma. Neuro-oncology, 2011, Volume: 13, Issue:12 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Brain; Brain Neoplasms; Case-Control Studies; Chemoradiotherapy; Chemotherapy, Adjuvant; Clinical Trials, Phase III as Topic; Dacarbazine; DNA Methylation; DNA, Neoplasm; Female; Follow-Up Studies; Glioblastoma; Gliosarcoma; Humans; Immunoenzyme Techniques; Indoles; Male; Middle Aged; Neoplasm Staging; Pharmacogenetics; Polymerase Chain Reaction; Prospective Studies; Survival Rate; Temozolomide; Treatment Outcome; Young Adult	2011
A phase II study of temozolomide vs. procarbazine in patients with glioblastoma multiforme at first relapse. British journal of cancer, 2000, Volume: 83, Issue:5 Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Brain Neoplasms; Dacarbazine; Disease-Free Survival; Female; Glioblastoma; Gliosarcoma; Humans; Male; Middle Aged; Procarbazine; Prognosis; Quality of Life; Recurrence; Temozolomide; Time Factors	2000

Other Studies

20 other study(ies) available for dacarbazine and Gliosarcoma

Article	Year
Survival outcomes associated with MGMT promoter methylation and temozolomide in gliosarcoma patients. Journal of neuro-oncology, 2022, Volume: 158, Issue:1 Topics: Antineoplastic Agents, Alkylating; Brain Neoplasms; Dacarbazine; DNA Methylation; DNA Modification Methylases; DNA Repair Enzymes; Glioblastoma; Gliosarcoma; Humans; Temozolomide; Tumor Suppressor Proteins	2022
The clinical, radiological, and immunohistochemical characteristics and outcomes of primary intracranial gliosarcoma: a retrospective single-centre study. Neurosurgical review, 2021, Volume: 44, Issue:2 Topics: Adult; Aged; Antineoplastic Agents, Alkylating; Brain Neoplasms; Dacarbazine; Female; Gliosarcoma; Humans; Immunohistochemistry; Male; Middle Aged; Neoplasm Recurrence, Local; Progression-Free Survival; Retrospective Studies; Risk Factors; Salvage Therapy; Temozolomide; Treatment Outcome	2021
Local delivery of angiogenesis-inhibitor minocycline combined with radiotherapy and oral temozolomide chemotherapy in 9L glioma. Journal of neurosurgery, 2014, Volume: 120, Issue:3 Topics: Administration, Oral; Angiogenesis Inhibitors; Animals; Antineoplastic Agents, Alkylating; Brain Neoplasms; Chemoradiotherapy; Combined Modality Therapy; Dacarbazine; Disease Models, Animal; Drug Delivery Systems; Female; Gliosarcoma; Minocycline; Neoplasm Transplantation; Polymers; Rats; Rats, Inbred F344; Temozolomide	2014
Pediatric gliosarcoma treated with adjuvant radiotherapy and temozolomide. Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery, 2015, Volume: 31, Issue:12 Topics: Adolescent; Antineoplastic Agents, Alkylating; Brain Neoplasms; Child; Combined Modality Therapy; Dacarbazine; Female; Follow-Up Studies; Gliosarcoma; Humans; Male; Retrospective Studies; Survival Analysis; Survival Rate; Temozolomide; Young Adult	2015
Radiotherapy plus concomitant temozolomide in primary gliosarcoma. Journal of neuro-oncology, 2016, Volume: 128, Issue:2 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Alkylating; Brain Neoplasms; Chemoradiotherapy; Dacarbazine; DNA Methylation; DNA Modification Methylases; DNA Repair Enzymes; Female; Gliosarcoma; Humans; Isocitrate Dehydrogenase; Male; Microsurgery; Middle Aged; Multivariate Analysis; Neurosurgical Procedures; Proportional Hazards Models; Retrospective Studies; Telomerase; Temozolomide; Tumor Suppressor Proteins	2016
Prognostic and therapeutic factors of gliosarcoma from a multi-institutional series. Journal of neuro-oncology, 2016, Volume: 129, Issue:1 Topics: Adult; Aged; Antineoplastic Agents, Alkylating; Brain Neoplasms; Combined Modality Therapy; Dacarbazine; Disease-Free Survival; Female; Gliosarcoma; Humans; Male; Middle Aged; Radiotherapy; Retrospective Studies; Salvage Therapy; Temozolomide; Treatment Outcome; Young Adult	2016
Enhancement of survival of 9L gliosarcoma bearing rats following intracerebral delivery of drugs in combination with microbeam radiation therapy. European journal of radiology, 2008, Volume: 68, Issue:3 Suppl Topics: Animals; Antineoplastic Agents, Alkylating; Brain Neoplasms; Cell Line, Tumor; Chemotherapy, Adjuvant; Dacarbazine; Gliosarcoma; Injections, Intralesional; Male; Radiotherapy, High-Energy; Rats; Rats, Inbred F344; Survival Analysis; Survival Rate; Synchrotrons; Temozolomide; Treatment Outcome	2008
Enhanced antitumor effect of combined-modality treatment using convection-enhanced delivery of hydrophilic nitrosourea with irradiation or systemic administration of temozolomide in intracranial brain tumor xenografts. Neurological research, 2008, Volume: 30, Issue:9 Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Cell Line, Tumor; Combined Modality Therapy; Convection; Cranial Irradiation; Dacarbazine; Disease Models, Animal; Drug Delivery Systems; Gliosarcoma; Injections, Intraperitoneal; Male; Nimustine; Rats; Rats, Inbred F344; Survival Analysis; Survival Rate; Temozolomide; Treatment Outcome; Xenograft Model Antitumor Assays	2008
Erythropoietin augments survival of glioma cells after radiation and temozolomide. International journal of radiation oncology, biology, physics, 2008, Nov-01, Volume: 72, Issue:3 Topics: Animals; Antineoplastic Agents, Alkylating; Brain Neoplasms; Cell Division; Cell Line, Tumor; Cell Movement; Cell Survival; Combined Modality Therapy; Dacarbazine; Erythropoietin; Glioma; Gliosarcoma; Humans; Mice; Mice, Nude; Neoplasm Transplantation; Temozolomide; Transplantation, Heterologous	2008
Efficacy of temozolomide treatment in patients with high-grade glioma. Anticancer research, 2009, Volume: 29, Issue:3 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; Chemotherapy, Adjuvant; Combined Modality Therapy; Dacarbazine; Etoposide; Female; Glioblastoma; Gliosarcoma; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Oligodendroglioma; Prognosis; Temozolomide; Treatment Outcome; Tumor Necrosis Factor-alpha	2009
Secondary gliosarcoma after diagnosis of glioblastoma: clinical experience with 30 consecutive patients. Journal of neurosurgery, 2010, Volume: 112, Issue:5 Topics: Adult; Aged; Antineoplastic Agents; Brain Neoplasms; Combined Modality Therapy; Dacarbazine; Female; Glioblastoma; Gliosarcoma; Humans; Male; Middle Aged; Retrospective Studies; Temozolomide	2010
Clinical characteristics and outcomes for a modern series of primary gliosarcoma patients. Cancer, 2010, Mar-01, Volume: 116, Issue:5 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Alkylating; Brain Neoplasms; Chemotherapy, Adjuvant; Combined Modality Therapy; Dacarbazine; Female; Gliosarcoma; Humans; Male; Middle Aged; Temozolomide	2010
Combination of 6-thioguanine, capecitabine, and celecoxib with temozolomide or lomustine for recurrent high-grade glioma. Journal of neuro-oncology, 2011, Volume: 102, Issue:2 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Capecitabine; Celecoxib; Dacarbazine; Deoxycytidine; Female; Fluorouracil; Glioblastoma; Gliosarcoma; Humans; Lomustine; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Recurrence, Local; Prospective Studies; Pyrazoles; Sulfonamides; Survival Rate; Temozolomide; Thioguanine; Treatment Outcome; Young Adult	2011
Intracranial microcapsule drug delivery device for the treatment of an experimental gliosarcoma model. Biomaterials, 2011, Volume: 32, Issue:10 Topics: Animals; Brain; Brain Neoplasms; Capsules; Dacarbazine; Disease Models, Animal; Drug Delivery Systems; Gliosarcoma; Immunohistochemistry; In Situ Nick-End Labeling; Kinetics; Rats; Rats, Inbred F344; Temozolomide	2011
Primary gliosarcoma--clinical experience from a regional cancer centre in north India. British journal of neurosurgery, 2011, Volume: 25, Issue:6 Topics: Adult; Antineoplastic Agents, Alkylating; Brain Neoplasms; Cancer Care Facilities; Combined Modality Therapy; Dacarbazine; Developing Countries; Female; Follow-Up Studies; Gliosarcoma; Humans; India; Intracranial Hypertension; Kaplan-Meier Estimate; Karnofsky Performance Status; Lost to Follow-Up; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Recurrence, Local; Psychomotor Disorders; Salvage Therapy; Survival Rate; Temozolomide; Treatment Outcome; Young Adult	2011
Improvement in the standard treatment for experimental glioma by fusing antibody Fc domain to endostatin. Journal of neurosurgery, 2011, Volume: 115, Issue:6 Topics: Administration, Oral; Angiogenesis Inhibitors; Animals; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Dacarbazine; Disease Models, Animal; Drug Delivery Systems; Endostatins; Gliosarcoma; Immunoglobulin Fc Fragments; Male; Rats; Rats, Inbred F344; Survival Analysis; Temozolomide	2011
Intracranial MEMS based temozolomide delivery in a 9L rat gliosarcoma model. Biomaterials, 2012, Volume: 33, Issue:23 Topics: Animals; Antineoplastic Agents, Alkylating; Brain Neoplasms; Dacarbazine; Drug Delivery Systems; Equipment Design; Female; Gliosarcoma; Rats; Rats, Inbred F344; Temozolomide	2012
Sarcomatous evolution of oligodendroglioma ("oligosarcoma"): confirmatory report of an uncommon pattern of malignant progression in oligodendroglial tumors. Pathology, research and practice, 2012, Dec-15, Volume: 208, Issue:12 Topics: Adult; Antineoplastic Agents, Alkylating; Brain Neoplasms; Chromosome Deletion; Chromosomes, Human, Pair 1; Chromosomes, Human, Pair 19; Combined Modality Therapy; Dacarbazine; Disease Progression; Gliosarcoma; Humans; Isocitrate Dehydrogenase; Male; Mutation; Neoplasm Recurrence, Local; Neoplasms, Second Primary; Oligodendroglioma; Temozolomide	2012
Temozolomide use in adult patients with gliosarcoma: an evolving clinical practice. Journal of neuro-oncology, 2013, Volume: 112, Issue:1 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Alkylating; Brain Neoplasms; Dacarbazine; Female; Gliosarcoma; Humans; Kaplan-Meier Estimate; Longitudinal Studies; Male; Middle Aged; Multivariate Analysis; Retrospective Studies; Temozolomide; Treatment Outcome; Young Adult	2013
Reirradiation of recurrent high-grade gliomas using amino acid PET (SPECT)/CT/MRI image fusion to determine gross tumor volume for stereotactic fractionated radiotherapy. International journal of radiation oncology, biology, physics, 2005, Oct-01, Volume: 63, Issue:2 Topics: Adult; Aged; alpha-Methyltyrosine; Analysis of Variance; Antineoplastic Agents, Alkylating; Astrocytoma; Combined Modality Therapy; Dacarbazine; Dose Fractionation, Radiation; Female; Glioblastoma; Glioma; Gliosarcoma; Humans; Male; Methionine; Middle Aged; Neoplasm Recurrence, Local; Oligodendroglioma; Positron-Emission Tomography; Prospective Studies; Statistics, Nonparametric; Stereotaxic Techniques; Temozolomide; Tomography, Emission-Computed, Single-Photon	2005